| Product NDC: | 60505-0258 |
| Proprietary Name: | Desmopressin Acetate |
| Non Proprietary Name: | desmopressin acetate |
| Active Ingredient(s): | .2 mg/1 & nbsp; desmopressin acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60505-0258 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077414 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060307 |
| Package NDC: | 60505-0258-3 |
| Package Description: | 30 TABLET in 1 BOTTLE (60505-0258-3) |
| NDC Code | 60505-0258-3 |
| Proprietary Name | Desmopressin Acetate |
| Package Description | 30 TABLET in 1 BOTTLE (60505-0258-3) |
| Product NDC | 60505-0258 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | desmopressin acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060307 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | .2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |